The Benefits and Harms of Lung Cancer Screening in Individuals With Comorbidities

CONCLUSIONS: Comorbidities reduce LY gained from screening per 100,000 compared with no comorbidities, and our results can be used by clinicians when discussing the benefits and harms of screening in their patients with comorbidities.PMID:38450056 | PMC:PMC10915410 | DOI:10.1016/j.jtocrr.2024.100635

Source: Clinical Lung Cancer - March 7, 2024 Category: Cancer & Oncology Authors: Minal S Kale Keith Sigel Arushi Arora Bart S Ferket Juan Wisnivesky Chung Yin Kong Source Type: research